Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GIRK2 ELISA Kit (AC3423)
Cat.#: ASET-2012
Specifications
Description Human GIRK2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human GIRK2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.149 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 3-48 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1431 Human Kallikrein 6 ELISA Kit (AC2842) Quantitative inquiry ASET-1181 Rat BACE1 ELISA Kit (AC2592) Quantitative inquiry ASET-1100 Human IL-6 ELISA Kit (AC2511) Quantitative inquiry ASET-1856 Mouse P Cadherin ELISA Kit (AC3267) Quantitative inquiry ASET-1450 Human KCC2 ELISA Kit (AC2861) Quantitative inquiry ASET-1104 Human Plexin A2 ELISA Kit (AC2515) Quantitative inquiry ASET-2022 Human NOTCH3 ELISA Kit (AC3433) Quantitative inquiry ASET-1218 Rat GAPDH ELISA Kit (AC2629) Quantitative inquiry ASET-1730 Human Caspase-12 ELISA Kit (AC3141) Quantitative inquiry ASET-2442 Human Ephrin B2 ELISA Kit (AC3853) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket